Radiation study for limited spread cancer
Part of Cancer, Digestive system, Kidney & urinary, Lungs & breathing, Skin clinical trials.
This trial looks at whether giving radiation treatment to tumors in people with a limited number of metastases can help control the cancer. It is for adults with certain cancer types that have spread to specific organs, and who can manage daily activities with little or no help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- Your original cancer has been confirmed by biopsy as breast, prostate, lung, or colorectal cancer
- Your cancer has up to five metastases (spread spots) in bone, lung, lymph nodes, liver, or brain
- Your usual daily functioning is good (you have an ECOG score of 0 or 1, meaning fully active or limited but able to care for yourself)
- You have not had radiation before in the exact same body area being treated
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether treating each spot of cancer that has spread (but only a few spots) with focused radiation can help control breast cancer. It aims to see if this approach can stop the cancer from growing further without needing strong whole-body treatments right away.
This trial tests whether targeted radiation can control a few growing spots of breast cancer while the rest of the cancer stays stable on your current treatment. It aims to delay the need to switch to a new therapy.
This study tests a precise radiation technique called SABR to treat cancer that has spread to a few spots. It aims to see if this approach can help control the cancer better than usual treatment, especially for lung, prostate, colorectal, or other solid tumors with limited spread.
This trial tests whether adding focused, high-dose radiation (SABR) to standard drug therapy can better control cancer that has spread to a few spots in the body. It is for people starting or resuming cancer medicines for newly found or growing metastases.
This trial tests a precise, high-dose radiation treatment (SABR) for people whose cancer has spread to a few spots (up to 5) and is not growing in the brain or been previously treated with radiation in those same spots.
This trial tests a high-precision radiation therapy (called stereotactic ablative radiotherapy) to treat breast cancer that has spread to a limited number of spots in the body. It aims to control the cancer and improve outcomes, and you can join while on your first-line systemic treatment if the cancer is stable.
Hear when a new Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.